ID: ALA3246764

Max Phase: Preclinical

Molecular Formula: C6H9N5O

Molecular Weight: 167.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1c2[nH]cnc2C(=O)NC1N

Standard InChI:  InChI=1S/C6H9N5O/c1-11-4-3(8-2-9-4)5(12)10-6(11)7/h2,6H,7H2,1H3,(H,8,9)(H,10,12)

Standard InChI Key:  HMKCIYJVOHPNLC-UHFFFAOYSA-N

Associated Targets(Human)

Purine nucleoside phosphorylase 774 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 167.17Molecular Weight (Monoisotopic): 167.0807AlogP: -1.17#Rotatable Bonds: 0
Polar Surface Area: 87.04Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.69CX Basic pKa: 5.84CX LogP: -0.74CX LogD: -0.76
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.45Np Likeness Score: 0.14

References

1. Jordan F, Wu A..  (1978)  Stereoelectronic factors in the binding of substrate analogues and inhibitors to purine nucleoside phosphorylase isolated from human erythrocytes.,  21  (9): [PMID:31484] [10.1021/jm00207a008]

Source